Cite
HARVARD Citation
Delyon, J. et al. (2022). PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study. Lancet oncology. 23 (4), pp. 491-500. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Delyon, J. et al. (2022). PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study. Lancet oncology. 23 (4), pp. 491-500. [Online].